QuantumSi is trading at $1.43, up +5.15%, with no specific catalyst established. - No clear company-specific announcement explaining the October 13 move was identified. - QuantumSi’s latest reported development was its October 8 update on detecting 19 amino acids in its Proteus program, which predates the move. - The biotech sector is down 2.01% in the supplied market context, while major indices are only modestly lower; neither explains the gain.